Koki Shimizu, Takuya Yamashita, Yuria Fukuda, Reiko Ito, Ryosuke Koyamada, Shinichiro Mori (Hematol., St.Luke's International Hospital, Tokyo, Japan)
Session information
Poster Session
Sat.Oct,12
Poster Session 2-28 Transplant Outcomes (2)
Sat. Oct 12, 2019 5:40 PM - 6:20 PM Poster (Tokyo International Forum, B2F Hall E)
Chair: Hirohisa Nakamae (Hematology, Graduate School of Medicine, Osaka City University)
Cheng-Hong Tsai1,2,3, Chi-Cheng Li4, Bor-Sheng Ko1, Feng-Min Tien1,2, Szu-Chun Hsu1, Chien-Ting Lin1,2, Ming Yao1, Jih-Luh Tang1,2 (1.Division of Hematology, Department of Internal Medicine, National Taiwan University Hospital, Taiwan, Taipei City, Taiwan, Taiwan, 2.Tai-Cheng Stem Cell Therapy Center, National Taiwan University, Taipei City, Taiwan, Taiwan, 3.Genome and Systems Biology Degree Program, National Taiwan University, Taipei City, Taiwan, Taiwan, 4.Division of Hematology, Department of Internal Medicine, Tzu-Chi Hospital, Huan-Lian City, Taiwan, Taiwan)
Taku Kikuchi1, Takehiko Mori1, Kana Matsumoto2, Chikako Ohwada3, Masahiro Onoda4, Hiroaki Shimizu5, Hiroki Yokoyama6, Makoto Onizuka7, Yuho Najima8, Takayoshi Tachibana9, Kunihiko Morita2, Shinichiro Okamoto1 (1.Hematology, Keio University School of Medicine, Tokyo, Japan, 2.Doshisha Women's College of Liberal Arts, Kyoto, Japan, 3.Hematology, Chiba University Hopital, Chiba, Japan, 4.Internal Medicine, Chiba Aoba Municipal Hopital, Chiba, Japan, 5.Hematology, Gunma University Graduate School of Medicine, Gunma, Japan, 6.Oncology and Hematology, Jikei University School of Medicine, Tokyo, Japan, 7.Hematology and Oncology, Tokai University School of Medicine, Isehara, Japan, 8.Hematology, Tokyo Metropolitan Komagome Hospital, Tokyo, Japan, 9.Hematology, Kanagawa Cancer Center, Yokohama, Japan)
Katsuhiro Konno1,2, Takenobu Nii2, Mami Shigeto2, Ayako Kaneyuki2, Daisuke Sugiyama2 (1.Graduate School of Medical Sciences, Kyushu Univ., Fukuoka, Japan, 2.Incubation Center for Advanced Medical Science, Kyushu Univ., Fukuoka Japan)
[PS2-28-5] Effective harvest of autologous PBSC supported by G-CSF and plerixafor in our institution
Mihoko Morita1, Yasufumi Matsuda2, Naoko Ida1, Kazuhiro Itoh1, Miyuki Okura1, Eiju Negoro3, Naoko Hosono1, Takahiro Yamauchi1 (1.Hematology and Oncology, University of Fukui, Japan, 2.Blood Transfusion, University of Fukui, Japan, 3.Cancer Care Promotion Center, University of Fukui, Japan)
Hirotaka Nakamura, Yuki Oku, Naoki Yuhi, Chika Yamada, Tomohiro Taya, Noriko Sugino, Kohei Tada, Masaharu Tashima, Hitomi Kaneko, Kazuo Hatanaka, Chisato Mizutani, Kazunori Imada (Osaka Red Cross Hospital, Osaka, Japan)
Ankur Jain, Alka Khadwal, Manupdesh Singh Sachdeva, Neelam Varma, Pankaj Malhotra, Subhash Varma, Gaurav Prakash, Deepesh Lad (Postgraduate Institute of Medical Education and Research, Chandigarh, India, Chandigarh, Chandigarh, Republic of India)
Nao Takasugi1, Keita Hogetsu1, Yuichi Mitani1, Kentaro Watanabe1, Junko Takita3, Akira Oka1, Mitsuteru Hiwatari1,2 (1.Department of Pediatrics, University of Tokyo, Tokyo, Japan, 2.Department of Cell Therapy and Transplant Medicine, University of Tokyo, 3.Department of Pediatrics, University of Kyoto, Kyoto, Japan)